Preferred Name |
elotuzumab |
|
Synonyms |
HuLuc63 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C546027 |
|
altLabel |
HuLuc63 Empliciti PDL-063 PDL063 BMS-901608 |
|
cui |
C1832049 C2987599 C4060058 C4083044 C4521041 |
|
HM |
D061067 |
|
Inverse of RB |
1351PE5UGS |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20100103 |
|
MeSH Frequency |
167 |
|
MMR |
20191031 |
|
notation |
C546027 |
|
PA |
D000970 |
|
PI |
*ANTIBODIES, MONOCLONAL (2010-2011) |
|
prefLabel |
elotuzumab |
|
SC |
1 |
|
Scope Statement |
a humanized monoclonal antibody that selectively targets glycoproteins expressed on myeloma cells |
|
SRC |
Mol Cancer Ther 2009 Sep;8(9):2616-24 |
|
TERMUI |
T000892944 T763372 T000966364 T763373 T000966363 T000966362 |
|
TH |
NLM (2016) NLM (2020) FDA SRS (2017) USAN (19XX) INN (19XX) NLM (2010) |
|
tui |
T116 T129 T121 |
Create mapping